Saturday 17 October 2026
Export OPK’s income statement to Excel — free account
OPKO Health, Inc.
OPK Healthcare Diagnostics & Research
OPKO Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.9 million, down 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS grew 94.7%, free cash flow grew 46.5% and total debt rose 6.37%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.53
0.08
−4.97%
Follow OPK
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 79.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 3 | 3 | 1 | 5 | 7 | 2 | 4 | 2 | 5 |
P/S ratio |
1.56 | 1.43 | 1.37 | 0.87 | 1.76 | 1.76 | 0.97 | 1.71 | 2.88 | 4.48 |
Altman Z-Score |
(0.42) | (0.23) | (0.07) | (0.07) | 2.75 | 1.78 | (0.12) | 1.05 | 1.67 | 4.57 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 50.11 | 0.00 | 0.00 | 0.00 | 0.00 | 1,021.88 |
Altman Z″-Score (non-manufacturers) |
(0.79) | (0.41) | (1.08) | (0.19) | 1.82 | 0.79 | (0.28) | 0.87 | 0.65 | 2.68 |
Beneish M-Score |
(2.81) | (2.33) | (2.97) | (3.37) | (2.63) | (1.71) | (2.94) | (2.72) | (3.04) | (1.91) |
P/Operating CF |
(36.51) | (22.97) | (30.82) | (27.74) | (552.41) | 73.87 | (19.01) | (48.91) | 1,317.08 | 165.22 |
P/B ratio |
0.75 | 0.75 | 0.85 | 0.56 | 1.85 | 1.51 | 0.54 | 0.95 | 1.51 | 2.39 |
Price to Tangible BV |
3.54 | 4.65 | 23.29 | 6.17 | 3.70 | 4.90 | 2.12 | 3.56 | 6.28 | 8.03 |
EV/Sales |
1.51 | 1.43 | 1.54 | 0.97 | 1.79 | 1.89 | 1.12 | 1.71 | 2.82 | 4.38 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 32.42 | 18.87 | 0.00 | 0.00 | 0.00 | 18,694.23 |
EV/Operating CF |
(5.15) | (5.57) | (47.03) | (10.20) | 83.08 | 68.81 | (5.86) | (15.51) | (29.63) | 152.72 |
EV/FCF |
(4.58) | (4.68) | (25.62) | (7.60) | 51.20 | (685.78) | (5.19) | (11.62) | (19.31) | 998.81 |
Quick Ratio |
3.13 | 2.85 | 1.10 | 1.31 | 1.20 | 0.95 | 0.88 | 0.83 | 0.82 | 1.48 |
Current Ratio |
3.97 | 3.43 | 1.55 | 1.85 | 2.49 | 1.39 | 1.30 | 1.10 | 1.12 | 1.84 |
Net Debt/EBITDA |
1.33 | (0.04) | (2.89) | (0.81) | 0.69 | 1.29 | (0.76) | 0.02 | 0.29 | (431.49) |
Debt/Assets |
17.69% | 19.73% | 12.01% | 11.40% | 8.44% | 10.43% | 9.56% | 3.86% | 1.59% | 2.01% |
Debt/Equity |
0.27 | 0.32 | 0.17 | 0.16 | 0.12 | 0.15 | 0.14 | 0.05 | 0.02 | 0.03 |
Asset Turnover |
0.29 | 0.34 | 0.41 | 0.44 | 0.73 | 0.60 | 0.38 | 0.39 | 0.36 | 0.40 |
Operating CF/Net income |
0.79 | 3.45 | 0.15 | 0.29 | (1.27) | 1.29 | 0.55 | 0.71 | 0.30 | (0.66) |
Capex/Depreciation |
(0.12) | (0.25) | (0.13) | (0.21) | 0.43 | (0.39) | (0.13) | (0.27) | (0.38) | (0.23) |
Interest Coverage |
(1.08) | (3.20) | (11.63) | (18.77) | 0.99 | 2.63 | (12.74) | (14.40) | (41.88) | (12.99) |
| (17.14%) | (3.86%) | (12.80%) | (20.23%) | (1.80%) | 1.86% | (18.49%) | (8.42%) | (15.51%) | (2.38%) | |
| (10.92%) | (2.53%) | (9.04%) | (14.38%) | (1.24%) | 1.28% | (13.23%) | (6.07%) | (11.40%) | (1.74%) | |
ROIC |
(5.91%) | (6.95%) | (6.39%) | (8.54%) | 0.67% | 1.94% | (9.79%) | (5.98%) | (9.64%) | (3.05%) |
Return on Tangible Assets |
(44.33%) | (9.87%) | (102.17%) | (124.43%) | (5.26%) | 10.61% | (155.87%) | (87.91%) | (166.45%) | (14.09%) |
Average Days of Receivables |
54.28 | 60.40 | 52.15 | 46.27 | 53.40 | 72.80 | 54.48 | 53.04 | 62.54 | 71.95 |
Research and Development Expense of Revenue |
20.44% | 14.75% | 10.38% | 7.36% | 4.33% | 5.25% | 13.07% | 12.68% | 13.09% | 10.19% |
Selling, General and Administrative Expense of Revenue |
36.75% | 42.66% | 34.81% | 37.11% | 26.42% | 24.77% | 38.06% | 36.19% | 42.92% | 36.45% |
Intangible Assets out of Total Assets |
0.52 | 0.52 | 0.67 | 0.65 | 0.35 | 0.47 | 0.52 | 0.54 | 0.54 | 0.53 |
Share Based Compensation of Revenue |
1.77% | 1.55% | 1.32% | 1.84% | 0.77% | 0.62% | 1.49% | 2.20% | 2.93% | 3.82% |
Graham Net Nets |
(0.09) | (0.17) | (0.27) | (0.24) | 0.03 | (0.11) | (0.42) | (0.20) | (0.14) | (0.04) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.71 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(23.81%) | (5.09%) | (15.92%) | (36.07%) | (1.04%) | 1.27% | (36.05%) | (8.97%) | (11.07%) | (0.96%) |
Free Cash Flow Yield |
(21.19%) | (21.39%) | (4.39%) | (14.57%) | 2.00% | (0.16%) | (22.23%) | (8.60%) | (5.09%) | 0.10% |
Revenue per Share |
0.81 | 1.03 | 1.15 | 1.40 | 2.74 | 2.24 | 1.51 | 1.76 | 1.73 | 2.03 |
Operating CF per Share |
(0.24) | (0.26) | (0.04) | (0.13) | 0.06 | 0.06 | (0.29) | (0.19) | (0.16) | 0.06 |
Capex per Share |
(0.02) | (0.04) | (0.02) | (0.03) | 0.05 | (0.05) | (0.02) | (0.05) | (0.07) | (0.04) |
Free Cash Flow per Share |
(0.25) | (0.30) | (0.06) | (0.16) | 0.11 | 0.01 | (0.31) | (0.24) | (0.23) | 0.02 |
Cash per Share |
0.49 | 0.62 | 0.13 | 0.21 | 0.21 | 0.11 | 0.14 | 0.17 | 0.16 | 0.31 |
Shareholders Equity per Share |
1.69 | 1.97 | 1.85 | 2.17 | 2.60 | 2.61 | 2.71 | 3.18 | 3.30 | 3.80 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.69 | 1.97 | 1.85 | 2.17 | 2.60 | 2.61 | 2.71 | 3.18 | 3.30 | 3.80 |
Free Cash Flow |
(190.53) | (208.26) | (41.76) | (117.82) | 72.21 | 6.04 | (184.59) | (135.78) | (131.33) | 9.90 |
Working Capital |
435.20 | 468.99 | 109.42 | 181.05 | 493.01 | 147.70 | 74.93 | 29.41 | 36.83 | 220.31 |
Capital Expenditures |
(11.99) | (24.77) | (13.56) | (22.63) | 33.87 | (33.44) | (12.07) | (26.63) | (39.25) | (22.15) |
Net Current Asset Value |
(82.10) | (172.67) | (313.00) | (211.09) | 108.42 | (278.33) | (370.47) | (342.05) | (397.47) | (191.21) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 169.88 | 47.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.02 | (0.02) | 0.02 | 0.01 | 0.03 | 0.04 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 166.25 | 43.85 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.31 | 1.43 | 1.41 | 1.33 | 1.00 | 0.61 | 0.75 | 0.67 | 0.70 | 0.79 |
Cash ROIC |
(9.63%) | (9.33%) | (2.42%) | (6.01%) | 3.57% | 0.30% | (9.61%) | (6.85%) | (6.65%) | 0.43% |
Accounts Receivable Turnover |
5.83 | 5.91 | 6.89 | 5.19 | 6.50 | 6.82 | 6.48 | 6.40 | 5.01 | 5.40 |
Accounts Payable Turnover |
9.09 | 8.47 | 7.98 | 9.61 | 5.63 | 4.42 | 10.42 | 9.94 | 9.71 | 9.71 |
Inventory Turnover |
6.54 | 8.08 | 7.80 | 8.92 | 10.90 | 9.63 | 11.96 | 13.20 | 12.84 | 14.07 |
Average Days of Payables |
37.42 | 34.73 | 46.63 | 34.15 | 25.10 | 139.47 | 39.87 | 28.61 | 43.74 | 31.85 |
Days of Inventory on Hand |
59.92 | 41.91 | 43.97 | 37.76 | 26.46 | 54.01 | 34.07 | 25.53 | 29.04 | 28.19 |
Average Receivables |
104.14 | 120.70 | 125.35 | 193.47 | 272.98 | 210.47 | 139.26 | 154.71 | 192.90 | 207.08 |
Average Payables |
44.09 | 58.37 | 68.34 | 74.52 | 211.90 | 202.14 | 54.97 | 60.85 | 63.83 | 62.95 |
Average Inventory |
61.31 | 61.25 | 69.88 | 80.28 | 109.42 | 92.89 | 47.87 | 45.82 | 48.28 | 43.45 |
Average Assets |
2,066.08 | 2,105.96 | 2,089.48 | 2,283.49 | 2,436.39 | 2,391.17 | 2,380.17 | 2,520.51 | 2,678.29 | 2,782.90 |
Average Common Equity |
1,316.70 | 1,377.33 | 1,475.43 | 1,623.39 | 1,678.34 | 1,643.16 | 1,703.03 | 1,817.46 | 1,967.72 | 2,035.80 |
Columns are period end dates